//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
#MedCase - 3 months after starting secukinumab for psoriasis and ankylosing spondylitis, a patient developed chronic diarrhea. Investigation revealed #CrohnsDisease, which resolved after the IL-17A inhibitor was discontinued. 👉️ buff.ly/czsoXzP #MedSky
5h
Three months after starting secukinumab for psoriasis and ankylosing spondylitis, a patient developed chronic diarrhea. Investigation revealed Crohn's disease, which resolved after the IL-17A…
www.springermedicine.com
New-onset Crohn’s disease after secukinumab treatment
Springer Medicine